- Home
- PBYI vs AGL Comparison
PBYI vs AGL Comparison
Compare PBYI & AGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBYI
- AGL
- Stock Information
- Founded
- PBYI 2010
- AGL 2016
- Country
- PBYI United States
- AGL United States
- Employees
- PBYI N/A
- AGL N/A
- Industry
- PBYI Biotechnology: Pharmaceutical Preparations
- AGL Managed Health Care
- Sector
- PBYI Health Care
- AGL Health Care
- Exchange
- PBYI Nasdaq
- AGL Nasdaq
- Market Cap
- PBYI 263.4M
- AGL 276.6M
- IPO Year
- PBYI N/A
- AGL 2021
- Fundamental
- Price
- PBYI $4.91
- AGL $0.58
- Analyst Decision
- PBYI Strong Buy
- AGL Hold
- Analyst Count
- PBYI 1
- AGL 17
- Target Price
- PBYI $7.00
- AGL $2.79
- AVG Volume (30 Days)
- PBYI 635.5K
- AGL 10.4M
- Earning Date
- PBYI 11-06-2025
- AGL 11-04-2025
- Dividend Yield
- PBYI N/A
- AGL N/A
- EPS Growth
- PBYI 59.87
- AGL N/A
- EPS
- PBYI 0.74
- AGL N/A
- Revenue
- PBYI $211,995,000.00
- AGL $5,885,571,000.00
- Revenue This Year
- PBYI N/A
- AGL N/A
- Revenue Next Year
- PBYI N/A
- AGL $5.76
- P/E Ratio
- PBYI $6.61
- AGL N/A
- Revenue Growth
- PBYI N/A
- AGL 5.21
- 52 Week Low
- PBYI $2.32
- AGL $0.56
- 52 Week High
- PBYI $6.12
- AGL $6.08
- Technical
- Relative Strength Index (RSI)
- PBYI 46.97
- AGL 23.45
- Support Level
- PBYI $4.58
- AGL $0.60
- Resistance Level
- PBYI $6.12
- AGL $0.86
- Average True Range (ATR)
- PBYI 0.40
- AGL 0.07
- MACD
- PBYI -0.05
- AGL -0.01
- Stochastic Oscillator
- PBYI 20.06
- AGL 3.88
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis resulting into apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About AGL agilon health inc.
Agilon Health Inc is transforming healthcare by empowering primary care physicians for the health of the patients. The company enables physicians to create their own Medicare-centric globally capitated line of business. The company derives its revenue from Medical services.